Uncategorized

Tirzepatide: A Comprehensive Review of Its Metabolic Benefits for Weight Loss and Type 2 Diabetes Over the past few years, tirzepatide has become one of the most discussed medications in the fields of obesity management and type 2 diabetes treatment. Its growing popularity is supported by large international clinical trials demonstrating remarkable weight loss, improved […]

Tirzepatide May Change How the Body Uses Energy Washington, DC, June 15, 2026 Anti-obesity medication activates brown adipose tissue that burns calories Tirzepatide doesn’t just help people lose weight — it also activates brown adipose tissue, representing a major breakthrough in obesity research, according to a study to be presented on Monday at ENDO 2026,

Tirzepatide once weekly for the treatment of obesity: results from the SURMOUNT-1 study Tirzepatide is an innovative medication for the treatment of obesity that simultaneously activates GLP-1 and GIP receptors. This allows it to influence appetite regulation, glucose levels, and the body’s energy balance. Obesity is a chronic disease that significantly increases the risk of

Authored by: Kristina D. Carter, PharmD, MBA, MHA | Medical Reviewer: Kristina Aungst, PharmD Latest Revision: January 6, 2026 • Insights adapted from GoodRx   Key Takeaways: Administered via a once-weekly injection, Tirzepatide is commercially distributed under two distinct brands: Mounjaro (indicated for managing type 2 diabetes) and Zepbound (prescribed for chronic weight management and

Author: Kristina Palmer, MD | Reviewer: Alyssa Billingsley, PharmD Key Takeaways: Tirzepatide (Mounjaro) is FDA-approved for the treatment of type 2 diabetes. People using it usually lose weight. In November 2023, the FDA approved tirzepatide for weight management in people with or without diabetes under the brand name Zepbound. Tirzepatide is currently the only medication

Key takeaways: Tirzepatide is an injectable medication administered once weekly. It is available under two brand names: Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and obstructive sleep apnea treatment). The medication works by mimicking the action of two natural gut hormones. It stimulates the pancreas to release insulin after meals and reduces

Tirzepatide for Obesity Treatment: Results of the Large SURMOUNT-1 Study In 2022, the respected medical journal New England Journal of Medicine published the results of the large-scale SURMOUNT-1 clinical trial, which evaluated the effectiveness of tirzepatide for weight loss in people with obesity and excess body weight. Tirzepatide for weight loss is a modern medication

Mounjaro Instructions: How to Properly Inject Mounjaro (KwikPen) 2.5–15 mg Step-by-step instructions for using Mounjaro® (tirzepatide) for weight loss and weight management. 1 injection per week. What is Mounjaro®? Mounjaro® is a modern medication based on tirzepatide from Eli Lilly. It is available in convenient KwikPen® injector pens and is administered once a week subcutaneously.